The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial

Linda Dirven*, Martin J. Van Den Bent, Andrew Bottomley, Nelly Van Der Meer, Bronno Van Der Holt, Maaike J. Vos, Annemiek M E Walenkamp, Laurens V. Beerepoot, Monique C J Hanse, Jaap C. Reijneveld, Aja Otten, Filip Y F L De Vos, Marion Smits, Jacoline E C Bromberg, Walter Taal, Martin J B Taphoorn

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial'. Together they form a unique fingerprint.

Medicine & Life Sciences